GRIFOLS | GRF - Operating Expenses


GRIFOLS reported EUR1.65B in Operating Expenses for its fiscal quarter ending in September of 2026.





Operating Expenses Change Date
Alcon AG USD 2.78B 370M Jun/2026
Almirall EUR 531.16M 13.76M Jun/2026
Amadeus IT EUR 1.21B 39.6M Sep/2026
Amarin USD 51.48M 113K Dec/2025
argenx SE USD 1.24B 213M Sep/2026
AstraZeneca USD 11.55B 674M Sep/2026
Bayer EUR 9.92B 121M Sep/2026
Cie Automotive EUR 1.69B 20.74M Dec/2025
Demant DKK 10.79B 1.16B Jun/2026
Ence Energia y Celulosa EUR 222.51M 33.81M Sep/2026
Essilor EUR 12.52B 568M Jun/2026
Ferrovial EUR 4.21B 412M Jun/2026
Fresenius EUR 5.24B 19M Sep/2026
Fresenius Medical Care EUR 4.55B 229.7M Sep/2026
Genmab DKK 748M 77M Jun/2026
GlaxoSmithKline GBP 6.03B 227M Sep/2026
GRIFOLS EUR 1.65B 101M Sep/2026
Hikma Pharmaceutical USD 1.34B 702M Dec/2025
Inditex EUR 1.17B 5.83B Jun/2026
Lakefront Biotherapeutics EUR 55.62M 14.56M Jun/2026
Merck EUR 4.97B 630M Sep/2026
Novartis USD 9.88B 325M Sep/2026
Philips EUR 4.23B 478M Sep/2026
Roche Holding CHF 18.9B 2.12B Jun/2026
Sanofi EUR 10.51B 598M Sep/2026
Smith & Nephew USD 2.59B 71M Jun/2026
UCB EUR 2.96B 196M Dec/2025
Viscofan EUR 284.26M 8.82M Sep/2026